Boivin G, Gilbert C, Morissette M, Handfield J, Goyette N, Bergeron M G
Infectious Disease Research Center, CHUL, Sainte-Foy, Québec, Canada.
AIDS. 1997 Jun;11(7):867-73. doi: 10.1097/00002030-199707000-00005.
To study the temporal relationships between cytomegalovirus (CMV) viral load and specific UL97 mutations in polymorphonuclear leukocytes (PMNL) and plasma samples from a patient with AIDS who developed ganciclovir-resistant CMV retinitis.
Sequential PMNL and plasma samples were analysed for determination of the CMV viral load using non-molecular methods and a quantitative polymerase chain reaction (PCR) assay. Screening of the same samples for the most common mutations conferring ganciclovir resistance was performed using nested PCR and restriction enzyme analysis.
At the time of progression of CMV retinitis (after 6 months of ganciclovir), a rapid increase in the CMV DNA load was found in both PMNL and plasma samples. This increase paralleled the emergence of a specific mutation (V594) in the same samples and recovery of ganciclovir-resistant blood isolates. In this patient, however, the only tests that substantially predicted the progression of CMV disease were the quantitative PCR assay using PMNL and to a lesser extent the pp65 antigenemia assay.
Quantitative evaluation of the CMV viral load in PMNL using sensitive assays such as PCR appears to be a promising approach for monitoring antiviral therapy in subjects with AIDS. In addition, common mutations conferring ganciclovir resistance can be detected directly in PMNL and plasma samples.
研究一名患耐更昔洛韦巨细胞病毒视网膜炎的艾滋病患者多形核白细胞(PMNL)和血浆样本中巨细胞病毒(CMV)病毒载量与特定UL97突变之间的时间关系。
使用非分子方法和定量聚合酶链反应(PCR)检测法对连续的PMNL和血浆样本进行分析,以测定CMV病毒载量。使用巢式PCR和限制性酶切分析对相同样本进行筛选,以检测赋予更昔洛韦抗性的最常见突变。
在CMV视网膜炎进展时(更昔洛韦治疗6个月后),在PMNL和血浆样本中均发现CMV DNA载量迅速增加。这种增加与相同样本中特定突变(V594)的出现以及耐更昔洛韦血液分离株的恢复平行。然而,在该患者中,唯一能充分预测CMV疾病进展的检测方法是使用PMNL的定量PCR检测法,以及在较小程度上的pp65抗原血症检测法。
使用如PCR等灵敏检测法对PMNL中的CMV病毒载量进行定量评估,似乎是监测艾滋病患者抗病毒治疗的一种有前景的方法。此外,可直接在PMNL和血浆样本中检测赋予更昔洛韦抗性的常见突变。